Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $30.8B
1-Year Est. Return 20.65%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+20.65%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$29.6B
AUM Growth
+$2.54B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,389
New
Increased
Reduced
Closed

Top Buys

1 +$163M
2 +$139M
3 +$137M
4
CCI icon
Crown Castle
CCI
+$118M
5
NFLX icon
Netflix
NFLX
+$115M

Top Sells

1 +$130M
2 +$123M
3 +$108M
4
MAA icon
Mid-America Apartment Communities
MAA
+$77.2M
5
WELL icon
Welltower
WELL
+$73M

Sector Composition

1 Technology 30%
2 Real Estate 28.67%
3 Communication Services 10.86%
4 Consumer Discretionary 6.91%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQST icon
1226
Aquestive Therapeutics
AQST
$533M
$3K ﹤0.01%
500
AVXL icon
1227
Anavex Life Sciences
AVXL
$463M
$3K ﹤0.01%
314
CRVS icon
1228
Corvus Pharmaceuticals
CRVS
$1.49B
$3K ﹤0.01%
400
ELVN icon
1229
Enliven Therapeutics
ELVN
$1.78B
$3K ﹤0.01%
152
FTRE icon
1230
Fortrea Holdings
FTRE
$959M
$3K ﹤0.01%
328
GERN icon
1231
Geron
GERN
$938M
$3K ﹤0.01%
2,247
KURA icon
1232
Kura Oncology
KURA
$744M
$3K ﹤0.01%
297
MGTX icon
1233
MeiraGTx Holdings
MGTX
$598M
$3K ﹤0.01%
330
DFTX
1234
Definium Therapeutics
DFTX
$1.75B
$3K ﹤0.01%
242
PSNL icon
1235
Personalis
PSNL
$793M
$3K ﹤0.01%
400
RLAY icon
1236
Relay Therapeutics
RLAY
$1.76B
$3K ﹤0.01%
486
SANA icon
1237
Sana Biotechnology
SANA
$1.02B
$3K ﹤0.01%
767
SYRE icon
1238
Spyre Therapeutics
SYRE
$3.22B
$3K ﹤0.01%
206
TBPH icon
1239
Theravance Biopharma
TBPH
$707M
$3K ﹤0.01%
215
TNGX icon
1240
Tango Therapeutics
TNGX
$1.66B
$3K ﹤0.01%
355
TRVI icon
1241
Trevi Therapeutics
TRVI
$1.66B
$3K ﹤0.01%
305
URGN icon
1242
UroGen Pharma
URGN
$944M
$3K ﹤0.01%
160
XERS icon
1243
Xeris Biopharma Holdings
XERS
$1.01B
$3K ﹤0.01%
404
XNCR icon
1244
Xencor
XNCR
$910M
$3K ﹤0.01%
222
IOVA icon
1245
Iovance Biotherapeutics
IOVA
$1.75B
$2K ﹤0.01%
1,006
KALV icon
1246
KalVista Pharmaceuticals
KALV
$827M
$2K ﹤0.01%
154
KROS icon
1247
Keros Therapeutics
KROS
$420M
$2K ﹤0.01%
133
LXRX icon
1248
Lexicon Pharmaceuticals
LXRX
$681M
$2K ﹤0.01%
1,369
ABSI icon
1249
Absci
ABSI
$400M
$2K ﹤0.01%
600
ARCT icon
1250
Arcturus Therapeutics
ARCT
$215M
$2K ﹤0.01%
90